ABSTRACT
Introduction: In 2019, the SARS-CoV-2 coronavirus emerged, producing COVID-19, which caused a pandemic that spread rapidly around the world;in severe cases, it can trigger cytokine storm syndrome and lead to death. Cutaneous manifestations can be associated with the expression of the ACE2 receptor in keratinocytes, these have been described in the literature from different countries. This review seeks to document the skin presentations that have been described in patients with COVID-19 in Latin America. Methodology: We researched in nine databases for articles in Spanish, Portuguese and English, until March 10, 2021, using the terms: “Skin”, “Cutaneous manifestations”, “COVID-19”, “SARS-COV-2”, associating them with Latin American countries. Basic data was obtained from the patients, then a table was created in Microsoft Excel to analyze and compare this data. Results: 22 publications from nine countries were identified. We obtained information from 92 patients, predominantly female with an average age of 31.6 years. 99 dermatologic lesions were documented, in order of frequency: rash, wheals, petechiae-purpura and papules. In 70 patients the affected body segment was described, mainly the trunk, lower and upper limbs. We found 39 photographs and 5 histopathologies. The most indicated treatments were corticosteroids, antimalarials and recombinant interferon. Conclusions: Differences can be observed in the description of cutaneous manifestations caused by COVID-19, between Latin American publications and the ones found in other countries. There seems to be a specific pattern with a predominance of erythematous rash with wheals, while pseudo-perniosis was less representative.